tamsulosin

N/A

Report date: 2025/04/24 16:17:46
NME

Base Information

Drug Nametamsulosin
Drug Alias Nametamsulosintamsulosin 0.2 mgGLC-2-TA
ClassificationSmall molecules
Mechanisms of ActionAlpha-1a adrenergic receptor antagonists
TargetsAlpha-1a adrenergic receptor
Therapy Area/IndicationsUreteral Stent-Related SymptomUrinary RetentionUreteral Calculi +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryArmeniaUnited StatesEgypt +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGl Pharm Tech Corp
China Registration ClassN/A

Develop Information

Active CompaniesIl-Yang Pharmco LtdBerlin-Chemie Ag (Menarini Group)Trihealth Inc +[5] 
Inactive CompaniesGl Pharm Tech Corp
Active IndicationsUreteral Stent-Related SymptomUrinary RetentionUreteral Calculi
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A